Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
465 |
|
| Actual shortage: | 53 (11%) | |
| Anticipated shortage: | 21 (5%) | |
| Avoided shortage: | 9 (2%) | |
| Resolved: | 382 (82%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
51 (10%) |
|
Overdue reports |
12 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2024-01-30 | 2024-04-23 | 217816 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2024-01-30 | 2024-03-17 | 217829 |
| CARVEDILOL | 6.25MG | TABLET | Resolved | 2024-01-30 | 2024-02-13 | 217832 |
| ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-01-30 | 2024-02-09 | 217837 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-02-13 | 2024-04-04 | 219378 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-02-26 | 2024-05-02 | 220633 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2024-02-26 | 2024-04-23 | 220656 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2024-02-26 | 2024-03-09 | 220663 |
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-02-26 | 2024-04-04 | 220668 |
| SOLIFENACIN | 10MG | TABLET | Resolved | 2024-02-26 | 2024-03-08 | 220673 |
| TRAZODONE | 150MG | TABLET | Resolved | 2024-02-26 | 2024-04-23 | 220686 |
| PERINDOPRIL ERBUMINE | 2MG | TABLET | Resolved | 2024-02-28 | 2024-03-08 | 220840 |
| OLMESARTAN | 20MG | TABLET | Resolved | 2024-03-11 | 2024-05-29 | 221869 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2024-03-11 | 2024-05-29 | 221872 |
| DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2024-03-11 | 2024-04-23 | 221877 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-25 | 2024-04-23 | 223214 |
| SILDENAFIL | 100MG | TABLET | Resolved | 2024-03-25 | 2024-04-23 | 223262 |
| DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-25 | 2024-04-19 | 223265 |
| RISPERIDONE | 0.25MG | TABLET | Resolved | 2024-03-25 | 2024-05-17 | 223270 |
| GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-26 | 2024-05-29 | 223456 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |